An investigation of the relationship between latitude and multiple sclerosis severity in New Zealand

Multiple Sclerosis

Volumn 22, Issue 5, 2016, Pages 705-707

  Alla, Sridhar ^a   Pearson, John F ^b   Taylor, Bruce V ^c   Roxburgh, Richard ^d,e   Clarke, Glynnis ^b   Miller, David H ^a   Richardson, Ann ^f   Abernethy, David A ^g   Willoughby, Ernie ^d   Sabel, Clive E ^h,i   Mason, Deborah F ^a  

^a NEW ZEALAND BRAIN RESEARCH INSTITUTE   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF TASMANIA   (Australia)

^d AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF CANTERBURY   (New Zealand)

^g UNIVERSITY OF OTAGO   (New Zealand)

^h UNIVERSITY OF BRISTOL   (United Kingdom)

ⁱ CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

disability; latitude; Multiple sclerosis; New Zealand; prevalence

Indexed keywords

CONTROLLED STUDY; DEMOGRAPHY; DISABILITY SEVERITY; DISEASE DURATION; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HUMAN; LATITUDE; LETTER; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MULTIPLE SCLEROSIS; NEW ZEALAND; PREVALENCE; RELAPSE; ADULT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; YOUNG ADULT; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; MULTIPLE SCLEROSIS SEVERITY SCORE; NEUROLOGIC DISEASE ASSESSMENT; TELEHEALTH;

ADULT; HUMANS; MALE; MULTIPLE SCLEROSIS; NEW ZEALAND; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84961734870     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515605909     Document Type: Letter

References (10)

1. Simpson S Jr, Blizzard L, Otahal P, et al. Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis. J Neurol Neurosurg Psychiatry 2011; 82: 1132-1141.
2. Alonso A, Hernán MA,. Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology 2008; 71: 129-135.
3. Rosati G,. The prevalence of multiple sclerosis in the world: An update. Neurol Sci 2001; 22: 117-139.
4. Melcon MO, Gold L, Carra A, et al. Argentine Patagonia: prevalence and clinical features of multiple sclerosis. Mult Scler 2008; 14: 656-662.
5. Taylor BV, Pearson JF, Clarke G, et al. MS prevalence in New Zealand, an ethnically and latitudinally diverse country. Mult Scler 2010; 16: 1422-1431.
6. Kurtzke JF,. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
7. Richardson AK, Clarke G, Sabel CE, et al. Method for identifying eligible individuals for a prevalence survey in the absence of a disease register or population register. Intern Med J 20128; 42: 1207-1212.
8. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 Revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846.
9. Roxburgh RHSR, Seaman SR, Masterman T, et al. Multiple sclerosis severity score: Using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144-1151.
10. Lechner-Scott L, Kappos L, Hofman M, et al. Can the Expanded Disability Status Scale be assessed by telephone? Mult Scler 2003; 9: 154-159.